These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Association of Pharmaceutical Industry Marketing of Opioid Products With Mortality From Opioid-Related Overdoses. Hadland SE, Rivera-Aguirre A, Marshall BDL, Cerdá M. JAMA Netw Open; 2019 Jan 04; 2(1):e186007. PubMed ID: 30657529 [Abstract] [Full Text] [Related]
28. Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing: cross sectional ecological study. Fleischman W, Agrawal S, King M, Venkatesh AK, Krumholz HM, McKee D, Brown D, Ross JS. BMJ; 2016 Aug 18; 354():i4189. PubMed ID: 27540015 [Abstract] [Full Text] [Related]
29. Sunshine Act: shedding light on inaccurate disclosures at a gynecologic annual meeting. Thompson JC, Volpe KA, Bridgewater LK, Qeadan F, Dunivan GC, Komesu YM, Cichowski SB, Jeppson PC, Rogers RG. Am J Obstet Gynecol; 2016 Nov 18; 215(5):661.e1-661.e7. PubMed ID: 27319366 [Abstract] [Full Text] [Related]
30. Pharmaceutical opioid marketing and physician prescribing behavior. Beilfuss S, Linde S. Health Econ; 2021 Dec 18; 30(12):3159-3185. PubMed ID: 34562329 [Abstract] [Full Text] [Related]
31. Payments from drug companies to physicians are associated with higher volume and more expensive opioid analgesic prescribing. Zezza MA, Bachhuber MA. PLoS One; 2018 Dec 18; 13(12):e0209383. PubMed ID: 30566426 [Abstract] [Full Text] [Related]